Trending Stock News

As Core Laboratories N V Com (CLB) Shares Rose, Holder Disciplined Growth Investors Has Lowered Stake by $786,024; Northern Capital Management Trimmed Intl Business Mach. (IBM) Stake by $351,135

Core Laboratories N.V. (NYSE:CLB) Logo

Northern Capital Management Llc decreased its stake in Intl Business Mach. (IBM) by 13.58% based on its latest 2018Q1 regulatory filing with the SEC. Northern Capital Management Llc sold 2,295 shares as the company’s stock declined 9.42% with the market. The institutional investor held 14,610 shares of the computer manufacturing company at the end of 2018Q1, valued at $2.24M, down from 16,905 at the end of the previous reported quarter. Northern Capital Management Llc who had been investing in Intl Business Mach. for a number of months, seems to be less bullish one the $135.08B market cap company. The stock increased 0.19% or $0.2859 during the last trading session, reaching $147.1559. About 448,134 shares traded. International Business Machines Corporation (NYSE:IBM) has declined 6.24% since June 13, 2017 and is downtrending. It has underperformed by 18.81% the S&P500. Some Historical IBM News: 17/04/2018 – IBM 1Q OPERATING EPS $2.45, EST. $2.42; AFFIRMS YEAR VIEWS; 14/05/2018 – Apttus’ Intelligent Middle Office Platform on IBM Cloud Will Help Customers Generate Greater Revenue, Maximize Business Outcomes; 24/05/2018 – MariaDB TX 3.0 Delivers First Enterprise Open Source Database to Beat Oracle, Microsoft and IBM; 17/04/2018 – IBM: RECEIVED $810M IN SETTLEMENTS FROM TAX AUDITS; 17/04/2018 – Mainframe computers should help IBM extend the growth streak; 14/03/2018 – IBM Study: Responding to Cybersecurity lncidents Still a Major Challenge for Businesses; 06/03/2018 – Robin Systems announces extension of Hybrid Cloud support to Microsoft Azure as well as for SAP HANA, MS-SQL, IBM DB2 & Package; 24/05/2018 – UCG Technologies Launches into Healthcare with Acquisition of Contract Management SaaS Provider Contract Guardian, Inc; 16/05/2018 – FINJAN HOLDINGS – ON MAY 15, UNIT ENTERED INTO A PATENT ASSIGNMENT AND SUPPORT AGREEMENT WITH INTERNATIONAL BUSINESS MACHINES CORPORATION; 15/03/2018 – DNB Global IV Adds SunTrust Banks, Exits IBM

Disciplined Growth Investors Inc decreased its stake in Core Laboratories N V Com (CLB) by 2.13% based on its latest 2018Q1 regulatory filing with the SEC. Disciplined Growth Investors Inc sold 7,278 shares as the company’s stock rose 11.06% while stock markets declined. The institutional investor held 334,531 shares of the oilfield services and equipment company at the end of 2018Q1, valued at $36.20 million, down from 341,809 at the end of the previous reported quarter. Disciplined Growth Investors Inc who had been investing in Core Laboratories N V Com for a number of months, seems to be less bullish one the $5.54 billion market cap company. The stock increased 0.20% or $0.25 during the last trading session, reaching $125.35. About 57,914 shares traded. Core Laboratories N.V. (NYSE:CLB) has risen 22.19% since June 13, 2017 and is uptrending. It has outperformed by 9.62% the S&P500. Some Historical CLB News: 25/04/2018 – CORE LAB SEES 2Q REV. ABOUT $177M-$179M, EST. $178.0M; 19/04/2018 – Fisher Asset Buys New 1% Position in Core Laboratories; 25/04/2018 – CORE LABORATORIES NV CLB.N – QTRLY OPERATING MARGINS OF 19%, UP 400 BPS YEAR-OVER-YEAR; 25/04/2018 – Core Labs 1Q Rev $170M; 27/04/2018 – CORE LABORATORIES NV CLB.N : UBS RAISES TARGET PRICE TO $125 FROM $118; 20/04/2018 – Low profile hedge funds post high returns in year after New York Sohn conference; 04/04/2018 – Core Laboratories’ First Quarter 2018 Webcast At 7:30 A.M. CDT / 2:30 P.M. CEST On April 26, 2018; 25/04/2018 – Core Labs Sees 2Q EPS 64c-EPS 66c; 25/04/2018 – CORE LABORATORIES SEES 2Q EPS 64C TO 66C, EST. 66C; 25/04/2018 – CORE LABORATORIES NV – QTRLY REVENUE OF $170 MLN, UP MORE THAN 8% YEAR-OVER-YEAR

More recent Core Laboratories N.V. (NYSE:CLB) news were published by: Fool.com which released: “3 Energy Stocks to Buy in May” on May 15, 2018. Also Benzinga.com published the news titled: “EnerCom Updates List of Presenters for The Oil & Gas ConferenceĀ® 23” on June 13, 2018. Fool.com‘s news article titled: “3 Top Oil Stocks to Buy Now” with publication date: May 24, 2018 was also an interesting one.

Analysts await Core Laboratories N.V. (NYSE:CLB) to report earnings on July, 23. They expect $0.65 EPS, up 25.00% or $0.13 from last year’s $0.52 per share. CLB’s profit will be $28.73 million for 48.21 P/E if the $0.65 EPS becomes a reality. After $0.57 actual EPS reported by Core Laboratories N.V. for the previous quarter, Wall Street now forecasts 14.04% EPS growth.

Disciplined Growth Investors Inc, which manages about $4.06 billion and $5.09 billion US Long portfolio, upped its stake in Medidata Solutions Inc (NASDAQ:MDSO) by 101,398 shares to 932,254 shares, valued at $58.56 million in 2018Q1, according to the filing.

Among 23 analysts covering Core Laboratories (NYSE:CLB), 12 have Buy rating, 0 Sell and 11 Hold. Therefore 52% are positive. Core Laboratories had 55 analyst reports since August 24, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Thursday, July 20 by RBC Capital Markets. The stock has “Neutral” rating by Credit Suisse on Thursday, September 1. The stock has “Neutral” rating by Citigroup on Monday, April 30. RBC Capital Markets maintained the shares of CLB in report on Friday, June 16 with “Buy” rating. Cowen & Co maintained the shares of CLB in report on Friday, October 6 with “Hold” rating. The stock of Core Laboratories N.V. (NYSE:CLB) has “Neutral” rating given on Wednesday, July 26 by Citigroup. The stock of Core Laboratories N.V. (NYSE:CLB) has “Neutral” rating given on Wednesday, September 30 by Sterne Agee CRT. Howard Weil maintained it with “Sector Perform” rating and $105 target in Friday, January 29 report. The rating was maintained by RBC Capital Markets with “Buy” on Friday, September 1. The stock has “Neutral” rating by UBS on Wednesday, July 26.

Investors sentiment increased to 1.04 in Q1 2018. Its up 0.18, from 0.86 in 2017Q4. It increased, as 32 investors sold CLB shares while 103 reduced holdings. 34 funds opened positions while 107 raised stakes. 48.24 million shares or 2.68% less from 49.56 million shares in 2017Q4 were reported. 294,802 were accumulated by Schroder Investment Group Inc. Proshare Limited Liability Corp holds 0% or 6,643 shares. Conestoga Cap Advsrs Limited Company has 0.05% invested in Core Laboratories N.V. (NYSE:CLB). Synovus Fin Corporation owns 6,123 shares. 6,500 were reported by Fernwood Management Llc. Stevens Ltd Partnership has invested 0.07% in Core Laboratories N.V. (NYSE:CLB). 40,000 were reported by Fort Washington Inv Advisors Oh. Peak6 Invests Limited Partnership holds 0% of its portfolio in Core Laboratories N.V. (NYSE:CLB) for 932 shares. Legal General Gru Public Ltd stated it has 0.01% of its portfolio in Core Laboratories N.V. (NYSE:CLB). 27 were accumulated by Cwm Limited Liability Corp. Baystate Wealth Mgmt Ltd invested 0% in Core Laboratories N.V. (NYSE:CLB). 16 were reported by Kistler. Dekabank Deutsche Girozentrale stated it has 0.01% of its portfolio in Core Laboratories N.V. (NYSE:CLB). Howe And Rusling holds 0% of its portfolio in Core Laboratories N.V. (NYSE:CLB) for 118 shares. Aperio Group Lc owns 19,926 shares.

Since January 31, 2018, it had 1 insider purchase, and 2 selling transactions for $2.69 million activity. 610 International Business Machines Corporation (NYSE:IBM) shares with value of $99,659 were bought by WADDELL FREDERICK H. 5,000 shares were sold by Gherson Diane J, worth $780,000 on Monday, February 26.

Investors sentiment increased to 1.11 in Q1 2018. Its up 0.08, from 1.03 in 2017Q4. It increased, as 60 investors sold IBM shares while 560 reduced holdings. 117 funds opened positions while 570 raised stakes. 501.15 million shares or 0.58% less from 504.07 million shares in 2017Q4 were reported. Tower Bridge Advsrs owns 93,529 shares for 0% of their portfolio. Washington Trust Company invested in 0.52% or 57,381 shares. The New York-based Mackay Shields Ltd Liability Corporation has invested 0.42% in International Business Machines Corporation (NYSE:IBM). Elm Advsr Limited Liability Company invested in 0.81% or 6,862 shares. Ntv Asset Mngmt Lc, West Virginia-based fund reported 17,380 shares. Congress Asset Management Co Ma reported 1,971 shares or 0% of all its holdings. Omers Administration reported 0.04% of its portfolio in International Business Machines Corporation (NYSE:IBM). Ima Wealth Inc owns 2,724 shares. Savant Cap Ltd Com invested in 0.29% or 9,021 shares. Parsec Financial Inc stated it has 0.48% in International Business Machines Corporation (NYSE:IBM). Security National Bank & Trust Of So Dak has invested 1.23% in International Business Machines Corporation (NYSE:IBM). Wellington Shields Mgmt, New York-based fund reported 16,482 shares. Hudson Bay Cap Mgmt Ltd Partnership owns 0.15% invested in International Business Machines Corporation (NYSE:IBM) for 48,326 shares. Fin Advisory Serv has 0.16% invested in International Business Machines Corporation (NYSE:IBM) for 3,516 shares. Dowling Yahnke Ltd Liability Co holds 0.46% or 31,889 shares.

More notable recent International Business Machines Corporation (NYSE:IBM) news were published by: Seekingalpha.com which released: “IBM: Unimpressive And Overpriced” on June 05, 2018, also Seekingalpha.com with their article: “IBM will hire 1800 in France” published on May 23, 2018, Prnewswire.com published: “IBM Unveils Major Expansion of Cloud Capabilities; Industry Leaders ExxonMobil, Bausch + Lomb and Westpac Shift …” on June 11, 2018. More interesting news about International Business Machines Corporation (NYSE:IBM) were released by: 247Wallst.com and their article: “6 Most Important Things in Business Today” published on June 04, 2018 as well as Fool.com‘s news article titled: “IBM Unveils an AI Supercomputer” with publication date: June 11, 2018.

Analysts await International Business Machines Corporation (NYSE:IBM) to report earnings on July, 17. They expect $3.03 earnings per share, up 2.02% or $0.06 from last year’s $2.97 per share. IBM’s profit will be $2.78 billion for 12.14 P/E if the $3.03 EPS becomes a reality. After $2.45 actual earnings per share reported by International Business Machines Corporation for the previous quarter, Wall Street now forecasts 23.67% EPS growth.

Northern Capital Management Llc, which manages about $394.79 million and $388.09M US Long portfolio, upped its stake in Autonation Inc (NYSE:AN) by 9,475 shares to 71,730 shares, valued at $3.36M in 2018Q1, according to the filing. It also increased its holding in Iqvia Holdings Inc by 25,479 shares in the quarter, for a total of 43,054 shares, and has risen its stake in Drx (KNOW).

International Business Machines Corporation (NYSE:IBM) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *